Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Clinical trial NCT07326540 · RECRUITING

Trial details

NCT number: NCT07326540
Sponsor: BioVersys SAS
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hospital Acquired Bacterial Pneumonia (HABP)Ventilator Associated Bacterial Pneumonia (VABP)Colistin Resistanrt ABC Acinetobacter Baumannii-calcoaceticus Complex

Start date: 2026-03-27
Primary completion: 2027-12-30
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.